• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » ICAN, MediSapiens to launch clinical trials platform

ICAN, MediSapiens to launch clinical trials platform

January 28, 2015
CenterWatch Staff

The International Cancer Advocacy Network (ICAN), a Phoenix, Ariz.-based cancer patient advocacy and charitable organization, is collaborating with Finland-based bioinformatics company MediSapiens to launch Remission Coach this year. Remission Coach is a web-based solution, which provides oncology patients with a personalized platform for actively determining the most appropriate clinical trial for that patient's disease and treatment history.

Robert H. Tamis, M.D., ICAN's chairman of health information technology initiatives, said, "Remission Coach offers a secure, sophisticated, yet easy-to-use electronic interface for patients and their caregivers to safely enter and store clinical information, such as pathology and imaging reports, treatment history and molecular profiling data. The clinical trials industry and patients will be able to use Remission Coach for immediate access to critical information that will vastly improve and accelerate the recruitment of trial candidates while minimizing the notoriously crippling costs of patient accrual."

Only a very small percentage of late-stage cancer patients are informed by their oncology teams about clinical trials. This is not for lack of effort or caring, but typically is the result of time pressures that do not allow for investigation or follow-up among oncologist, clinical trial
sponsors and patient.

One of the many advances featured in Remission Coach is its predictive ability to match patients to ongoing clinical trials based on clinical histories and molecular profiling results. Patients can quickly seek clinical trials for which they are eligible, providing them with potential life-extending opportunities otherwise unknown to them.

Placing a high priority on patient security and privacy, Remission Coach is a HIPAA-compliant platform with a built-in system that anonymizes and de-identifies patient data. For biopharmaceutical, government and academic sponsors and principal investigators, Remission Coach features a dedicated researcher interface powered with intelligent filtering tools. This includes controlled search engine access to rapidly identify patient cases, on the basis of de-identified data, that are eligible for clinical trials.

When a match is found, the company, investigator, CRO or clinical trials recruiting team can send a contact request to the anonymous patient, who has the option of whether or not to respond to such a request.

Remission Coach provides "urgency to patients," said Scott M. Kahn, Ph.D., chairman of ICAN's Biomarkers Council, "while simultaneously enabling drug developers to expedite clinical trial enrollments and patient retention, thus significantly lowering the costs of patient accrual. Important short and long-term benefits of Remission Coach include accelerating clinical trial accrual and retention, expediting regulatory approval of novel patient therapies, and therefore making drugs available to cancer patients more quickly and more effectively."

Remission Coach provides patients and caregivers additional benefits since it can be used as a stand-alone option that brings personalized medicine and disease management to their fingertips. The easily navigable Remission Coach interface helps to distinguish between multiple, and often confusing, names for diseases, treatments, genes and other parameters. Patients can access their data securely and remotely, thereby providing them with a greater comfort level in talking with their medical teams and making decisions about their treatment.

    Upcoming Events

    • 05Dec

      Thriving in Clinical Research – Overcoming Common Challenges as a Site: Part 3 – Site Resourcing

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing